International Business Machines Corporation (IBM) is Attracting Investor Attention: Here is What You Should Know
Werte in diesem Artikel
IBM (IBM) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this technology and consulting company have returned +10.2% over the past month versus the Zacks S&P 500 composite's +5.8% change. The Zacks Computer - Integrated Systems industry, to which IBM belongs, has gained 4.2% over this period. Now the key question is: Where could the stock be headed in the near term?While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.IBM is expected to post earnings of $3.76 per share for the current quarter, representing a year-over-year change of -2.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +0%.The consensus earnings estimate of $10.12 for the current fiscal year indicates a year-over-year change of +5.2%. This estimate has changed +0.1% over the last 30 days.For the next fiscal year, the consensus earnings estimate of $10.58 indicates a change of +4.5% from what IBM is expected to report a year ago. Over the past month, the estimate has changed +0.2%.With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for IBM.The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSProjected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.For IBM, the consensus sales estimate for the current quarter of $17.61 billion indicates a year-over-year change of +1.3%. For the current and next fiscal years, $62.81 billion and $65.9 billion estimates indicate +1.5% and +4.9% changes, respectively.Last Reported Results and Surprise HistoryIBM reported revenues of $14.97 billion in the last reported quarter, representing a year-over-year change of +1.5%. EPS of $2.30 for the same period compares with $2.20 a year ago.Compared to the Zacks Consensus Estimate of $15.19 billion, the reported revenues represent a surprise of -1.46%. The EPS surprise was +1.32%.The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.IBM is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about IBM. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Business Machines Corporation (IBM): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Here
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Here
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu IBM Corp. (International Business Machines)
Analysen zu IBM Corp. (International Business Machines)
Datum | Rating | Analyst | |
---|---|---|---|
24.10.2024 | IBM Sell | UBS AG | |
24.10.2024 | IBM Hold | Jefferies & Company Inc. | |
01.10.2024 | IBM Halten | DZ BANK | |
25.01.2024 | IBM Hold | Jefferies & Company Inc. | |
25.01.2024 | IBM Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
21.04.2020 | IBM Outperform | Credit Suisse Group | |
19.07.2019 | IBM Outperform | Credit Suisse Group | |
11.04.2019 | IBM Outperform | Credit Suisse Group | |
10.12.2018 | Red Hat Buy | Monness, Crespi, Hardt & Co. | |
23.10.2018 | Red Hat Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
24.10.2024 | IBM Hold | Jefferies & Company Inc. | |
01.10.2024 | IBM Halten | DZ BANK | |
25.01.2024 | IBM Hold | Jefferies & Company Inc. | |
25.01.2024 | IBM Neutral | JP Morgan Chase & Co. | |
22.01.2024 | IBM Neutral | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
24.10.2024 | IBM Sell | UBS AG | |
19.07.2018 | IBM Sell | Société Générale Group S.A. (SG) | |
12.01.2018 | IBM Sell | Société Générale Group S.A. (SG) | |
17.07.2017 | IBM Underweight | Barclays Capital | |
12.07.2017 | IBM Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IBM Corp. (International Business Machines) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen